CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 54 filers reported holding CARDIFF ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,188 | -41.4% | 1,574 | -38.0% | 0.00% | – |
| Q2 2023 | $3,734 | -84.6% | 2,540 | -82.7% | 0.00% | – |
| Q1 2023 | $24,238 | +1020.1% | 14,690 | +850.2% | 0.00% | – |
| Q4 2022 | $2,164 | +8.2% | 1,546 | +7.3% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 1,441 | -16.3% | 0.00% | – |
| Q2 2022 | $4,000 | -92.6% | 1,722 | -92.1% | 0.00% | – |
| Q1 2022 | $54,000 | – | 21,698 | +361533.3% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 6 | -100.0% | 0.00% | – |
| Q1 2021 | $1,387,000 | -90.9% | 149,780 | -82.3% | 0.00% | -100.0% |
| Q4 2020 | $15,263,000 | +9.8% | 848,400 | -13.4% | 0.00% | 0.0% |
| Q3 2020 | $13,898,000 | – | 979,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |